"10.1371_journal.pmed.1001426","plos medicine","2013-04-16T00:00:00Z","Michael Haase; Anja Haase-Fielitz; Michael Plass; Hermann Kuppe; Roland Hetzer; Claire Hannon; Patrick T Murray; Michael J Bailey; Rinaldo Bellomo; Sean M Bagshaw","Department of Nephrology and Hypertension, Diabetes, and Endocrinology, Otto-von-Guericke-University Magdeburg, Germany; Department of Anesthesiology, The German Heart Center, Berlin, Germany; Department of Cardiothoracic Surgery, The German Heart Center, Berlin, Germany; Nephrology and Clinical Pharmacology, University College Dublin School of Medicine and Medical Science, Dublin, Ireland; The Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia; Department of Intensive Care, The Austin Hospital, Melbourne, Australia; Division of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Alberta, Canada","Conceived and designed the experiments: MH AHF RB. Performed the experiments: MH AHF RB PM SMB. Analyzed the data: MJB AHF. Contributed reagents/materials/analysis tools: MH AHF RB. Wrote the first draft of the manuscript: MH AHF. Contributed to the writing of the manuscript: MP HK RH CH PM MJB RB SMB. ICMJE criteria for authorship read and met: MH AHF RB MP HK RH CH PM MJB SMB. Agree with manuscript results and conclusions: MH AHF RB MP HK RH CH PM MJB SMB. Enrolled patients: MH AHF RB SMB PM.","MH and RB hold a patent on the use of sodium bicarbonate infusions to prevent acute kidney injury. MH, SMB, and PM received lecture fees from companies (incl. Abbott Diagnostics, Alere) involved in the development of neutrophil gelatinase-associated lipocalin as renal biomarker. The authors declare no other competing interests.","2013","04","Michael Haase","MH",10,TRUE,3,5,2,2,TRUE,FALSE,FALSE,0,NA,FALSE
